NO178108C - Salter av hydrazoner, farmasöytiske preparater inneholdende saltene samt anvendelse av saltene - Google Patents

Salter av hydrazoner, farmasöytiske preparater inneholdende saltene samt anvendelse av saltene

Info

Publication number
NO178108C
NO178108C NO924001A NO924001A NO178108C NO 178108 C NO178108 C NO 178108C NO 924001 A NO924001 A NO 924001A NO 924001 A NO924001 A NO 924001A NO 178108 C NO178108 C NO 178108C
Authority
NO
Norway
Prior art keywords
acids
acid
unsubstituted
substituted
salts
Prior art date
Application number
NO924001A
Other languages
English (en)
Norwegian (no)
Other versions
NO924001L (no
NO178108B (no
NO924001D0 (no
Inventor
Jaroslav Stanek
Jorg Frei
Giorgio Caravatti
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO924001D0 publication Critical patent/NO924001D0/no
Publication of NO924001L publication Critical patent/NO924001L/no
Publication of NO178108B publication Critical patent/NO178108B/no
Publication of NO178108C publication Critical patent/NO178108C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/18—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by doubly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/16—Compounds containing any of the groups, e.g. aminoguanidine
    • C07C281/18—Compounds containing any of the groups, e.g. aminoguanidine the other nitrogen atom being further doubly-bound to a carbon atom, e.g. guanylhydrazones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C249/00—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C249/16—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of hydrazones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/06—One of the condensed rings being a six-membered aromatic ring the other ring being four-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Detergent Compositions (AREA)
  • Cereal-Derived Products (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO924001A 1991-10-16 1992-10-15 Salter av hydrazoner, farmasöytiske preparater inneholdende saltene samt anvendelse av saltene NO178108C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH304191 1991-10-16

Publications (4)

Publication Number Publication Date
NO924001D0 NO924001D0 (no) 1992-10-15
NO924001L NO924001L (no) 1993-04-19
NO178108B NO178108B (no) 1995-10-16
NO178108C true NO178108C (no) 1996-01-24

Family

ID=4247296

Family Applications (1)

Application Number Title Priority Date Filing Date
NO924001A NO178108C (no) 1991-10-16 1992-10-15 Salter av hydrazoner, farmasöytiske preparater inneholdende saltene samt anvendelse av saltene

Country Status (24)

Country Link
EP (1) EP0538193B1 (cs)
JP (1) JP2788579B2 (cs)
KR (1) KR100265307B1 (cs)
AT (1) ATE145896T1 (cs)
AU (1) AU658931B2 (cs)
CA (1) CA2080545C (cs)
CY (1) CY2127B1 (cs)
CZ (1) CZ279601B6 (cs)
DE (1) DE59207617D1 (cs)
DK (1) DK0538193T3 (cs)
ES (1) ES2095444T3 (cs)
FI (1) FI112212B (cs)
GR (1) GR3021903T3 (cs)
HK (1) HK1005023A1 (cs)
HU (1) HU226954B1 (cs)
IL (1) IL103448A (cs)
MX (1) MX9205934A (cs)
NO (1) NO178108C (cs)
NZ (1) NZ244725A (cs)
RU (1) RU2081108C1 (cs)
SA (1) SA93130417B1 (cs)
SG (1) SG43185A1 (cs)
SK (1) SK279938B6 (cs)
ZA (1) ZA927957B (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2103166B1 (es) * 1992-08-26 1998-04-01 Ciba Geigy Ag Procedimiento para la obtencion de amidinohidrazonas biciclicas.
WO1996017930A1 (fr) * 1994-12-09 1996-06-13 Ajinomoto Co., Inc. Nouveau gene de decarboxylase de lysine et procede de production de lysine l
EP0808309B1 (en) * 1995-01-26 2004-10-06 Novartis AG Imidazole derivatives, their preparation and their use as s-adenosylmethionine decarboxylase (=samdc) inhibitors
JP2005519110A (ja) * 2002-03-04 2005-06-30 ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト 新規なケイ皮酸塩、その調製方法及び医薬品としての使用
GT200600316A (es) * 2005-07-20 2007-04-02 Sales de 4-metilo-n-(3-(4-metilo-imidazol-1-ilo)-5-trifluorometilo-fenilo)-3-(4-piridina-3-ilo-pirimidina-2-iloamino)- benzamida.
EP1884515A1 (en) 2006-07-31 2008-02-06 Laboratorios del Dr. Esteve S.A. Substituted indanyl sulfonamide compounds, their preparation and use as medicaments

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU645799B2 (en) * 1990-05-07 1994-01-27 Novartis Ag Hydrazones

Also Published As

Publication number Publication date
FI924650A7 (fi) 1993-04-17
HU9203234D0 (en) 1992-12-28
IL103448A0 (en) 1993-03-15
SG43185A1 (en) 1997-10-17
CZ279601B6 (cs) 1995-05-17
CA2080545A1 (en) 1993-04-17
NO924001L (no) 1993-04-19
SA93130417B1 (ar) 2005-11-12
FI112212B (fi) 2003-11-14
ES2095444T3 (es) 1997-02-16
JP2788579B2 (ja) 1998-08-20
ATE145896T1 (de) 1996-12-15
JPH05239011A (ja) 1993-09-17
SK315292A3 (en) 1995-04-12
RU2081108C1 (ru) 1997-06-10
KR930007896A (ko) 1993-05-20
GR3021903T3 (en) 1997-03-31
EP0538193B1 (de) 1996-12-04
FI924650A0 (fi) 1992-10-14
NO178108B (no) 1995-10-16
CA2080545C (en) 2005-11-29
NO924001D0 (no) 1992-10-15
EP0538193A3 (en) 1993-06-16
AU2704092A (en) 1993-04-22
EP0538193A2 (de) 1993-04-21
CY2127B1 (en) 2002-06-21
HK1005023A1 (en) 1998-12-18
DK0538193T3 (da) 1996-12-23
NZ244725A (en) 1995-05-26
IL103448A (en) 1998-01-04
SK279938B6 (sk) 1999-06-11
KR100265307B1 (ko) 2000-09-15
MX9205934A (es) 1993-04-01
ZA927957B (en) 1993-04-26
AU658931B2 (en) 1995-05-04
HU226954B1 (en) 2010-03-29
HUT63149A (en) 1993-07-28
DE59207617D1 (de) 1997-01-16
CZ315292A3 (en) 1993-05-12

Similar Documents

Publication Publication Date Title
DE3671370D1 (de) Zubereitungen zur behandlung von mycoplasmosen und bakteriellen erkrankungen bei gefluegel.
ES2191412T3 (es) Derivados de aminoacidos que contienen fluor.
NO172674C (no) Fremgangsmaate for fremstilling av basiske, vandige preparater av karboksylsyrer
ZA934997B (en) Use of 2-(N-(2-aminoethyl)amino)acetic acid derivatives
NO178108C (no) Salter av hydrazoner, farmasöytiske preparater inneholdende saltene samt anvendelse av saltene
ES8600243A1 (es) Procedimiento para la obtencion de compuestos de 2-hidroximetil-3-carbamoil-1,4-dihidropiridina
IE890177L (en) Piperidinyl derivatives
DE69201660D1 (de) Verwendung von Acetyl L-Carnitin zur therapeutischen Behandlung von Coma.
IL83086A (en) Stable,injectable solutions of vincristine salts
DE69209128D1 (de) Verwendung von Indazol-Methoxyalkansäure zur Herstellung eines Arzneimittels zur Behandlung von Autoimmunkrankheiten
ES2109988T3 (es) Derivados cefalosporinicos.
KR900700098A (ko) 발기부전의 치료겸 진단용 플라복세이트 및 그 유도체
ES461906A1 (es) Procedimiento para la obtencion de derivados benz-acilo-ben-zimidacol-2-carboxilicos.
SE8802814L (sv) Beredningar foer lokal anvaendning
SE8400629L (sv) Basiska oximetrar
KR890008151A (ko) 키놀린 카르복산의 유도체
ATE65991T1 (de) Cycloalkyl-substituierte 4-aminophenyl halo derivate und verfahren zur deren herstellung.
GB916139A (en) Quinazolone derivatives
NO950061L (no) 4-oksa-1-azabisyklo [3,2,0Å heptan-7-on-derivater som antitumormidler

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees